Correlation Between PsyBio Therapeutics and Regen BioPharma
Can any of the company-specific risk be diversified away by investing in both PsyBio Therapeutics and Regen BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PsyBio Therapeutics and Regen BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PsyBio Therapeutics Corp and Regen BioPharma, you can compare the effects of market volatilities on PsyBio Therapeutics and Regen BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PsyBio Therapeutics with a short position of Regen BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of PsyBio Therapeutics and Regen BioPharma.
Diversification Opportunities for PsyBio Therapeutics and Regen BioPharma
0.43 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between PsyBio and Regen is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding PsyBio Therapeutics Corp and Regen BioPharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regen BioPharma and PsyBio Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PsyBio Therapeutics Corp are associated (or correlated) with Regen BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regen BioPharma has no effect on the direction of PsyBio Therapeutics i.e., PsyBio Therapeutics and Regen BioPharma go up and down completely randomly.
Pair Corralation between PsyBio Therapeutics and Regen BioPharma
Assuming the 90 days horizon PsyBio Therapeutics Corp is expected to generate 2.65 times more return on investment than Regen BioPharma. However, PsyBio Therapeutics is 2.65 times more volatile than Regen BioPharma. It trades about 0.1 of its potential returns per unit of risk. Regen BioPharma is currently generating about 0.13 per unit of risk. If you would invest 0.01 in PsyBio Therapeutics Corp on September 2, 2024 and sell it today you would earn a total of 0.00 from holding PsyBio Therapeutics Corp or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
PsyBio Therapeutics Corp vs. Regen BioPharma
Performance |
| Timeline |
| PsyBio Therapeutics Corp |
| Regen BioPharma |
PsyBio Therapeutics and Regen BioPharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with PsyBio Therapeutics and Regen BioPharma
The main advantage of trading using opposite PsyBio Therapeutics and Regen BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PsyBio Therapeutics position performs unexpectedly, Regen BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regen BioPharma will offset losses from the drop in Regen BioPharma's long position.| PsyBio Therapeutics vs. Rigel Pharmaceuticals | PsyBio Therapeutics vs. Geron | PsyBio Therapeutics vs. Verastem | PsyBio Therapeutics vs. Immutep Ltd ADR |
| Regen BioPharma vs. Therapeutic Solutions International | Regen BioPharma vs. Alpha Cognition | Regen BioPharma vs. Regen BioPharma | Regen BioPharma vs. Vg Life Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |